Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates.
Journal: Journal of visualized experiments : JoVE
Published: May 26, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers.
Journal: Cytotherapy
Published: March 07, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial.
Journal: The Lancet. Oncology
Published: January 09, 2025
A genetically engineered, stem-cell-derived cellular vaccine.
Journal: Cell reports. Medicine
Published: July 04, 2022
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair.
Journal: Nature biomedical engineering
Published: February 04, 2022
Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
Journal: Journal of virology
Published: July 21, 2021
Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics.
Journal: Scientific reports
Published: January 31, 2021
Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly.
Journal: Journal of virology
Published: January 14, 2021
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.
Journal: Med (New York, N.Y.)
Published: November 27, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026